New oral anticoagulants in primary care: The general practitioner's point of view

被引：0

作者：

Frappe, Paul ^{[1
,2
,3
]}

Liebart, Sandra ^{[1
,2
]}

机构：

[1] Univ St Etienne, Dept Med Gen, F-42023 St Etienne, France

[2] Univ St Etienne, Grp Rech Thrombose, EA3065, F-42023 St Etienne, France

[3] Inserm DGOS, CIE3, F-42055 St Etienne, France

来源：

PRESSE MEDICALE | 2013年 / 42卷 / 09期

关键词：

ATRIAL-FIBRILLATION; DECISION-MAKING; RISK; DABIGATRAN; MANAGEMENT; PHYSICIANS; COMMUNITY; WARFARIN; PATIENT; DRUGS;

D O I：

10.1016/j.lpm.2013.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The assessment of new anticoagulants benefits is based on the assessment of thromboembolism and bleeding risks, referring when possible to CHA(2)DS(2)-VASc and HAS-BLED scores. The management of patients treated with new anticoagulants includes a clinical assessment and the annual measure of the creatinine clearance (three times per year in some particular cases). New anticoagulants make hemostasis tests not reliable. The general practitioner has a role in preventing interactions and reporting potential adverse drug reactions. The context of uncertainty about the risk/benefit ratio of new anticoagulants emphasizes the need to integrate the values of the patient in treatment decisions.

引用

页码：1267 / 1273

页数：7

共 50 条

[21] The announcement of the diagnosis of cancer: point of view of the general practitioner
Ferraton-Rollin, Marie
Magne, Nicolas
Gonthier, Regis
Merrouche, Yacine
Bois, Christophe
BULLETIN DU CANCER, 2013, 100 (10) : 955 - 962
[22] Oral cancer awareness for the general practitioner: new approaches to patient care
Farah, C. S.
McCullough, M. J.
AUSTRALIAN DENTAL JOURNAL, 2008, 53 (01) : 2 - 10
[23] General characteristics of the new oral anticoagulants
Gegu, Marine
Chevalet, Pascal
Piloquet, Francois-Xavier
Berrut, Gilles
De Decker, Laure
GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2013, 11 : 4 - 9
[24] New medicines in primary care: a review of influences on general practitioner prescribing
Mason, A.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (01) : 1 - 10
[25] New oral anticoagulants: A view from the laboratory
Weitz, Jeffrey I.
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 : S133 - S136
[26] The nomenclature and classification of lung tuberculosis from the general practitioner's point of view.
Bacmeister, A
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1918, 44 : 340 - 342
[27] Poor-law reform from a general practitioner's point of view.
Harford, MS
LANCET, 1910, 2 : 760 - 761
[28] USE OF COUMARINIC ORAL ANTICOAGULANTS IN PRIMARY CARE
Carracedo Martinez, E.
ATENCION FARMACEUTICA, 2008, 10 (04): : 246 - 250
[29] Concept of a point of care test to detect new oral anticoagulants in urine samples
Harenberg J.
Krämer S.
Du S.
Weiss C.
Krämer R.
Thrombosis Journal, 11 (1)
[30] Fetomaternal hemorrhage: Practitioner's point of view
Huissoud, C.
Divry, V.
Rudigoz, R. -C.
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2009, 38 (04): : 286 - 297

← 1 2 3 4 5 →